Group One Trading, L.P. Vista Gen Therapeutics, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.3 $4,298 - $10,747	-35,824 Reduced 26.63%	98,721 $11,000
Q4 2022 Feb 09, 2023	SELL	$0.09 - $4.8 $26,269 - $1.4 Million	-291,884 Reduced 68.45%	134,545 $13,000
Q3 2022 Nov 09, 2022	BUY	$0.14 - $4.8 $40,681 - $1.39 Million	290,585 Added 213.91%	426,429 $65,000
Q2 2022 Aug 11, 2022	BUY	$0.88 - $1.73 $119,542 - $235,010	135,844 New	135,844 $120,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.